{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-024938","form_type":"8-K","ticker":"SSII","cik":"0001676163","company_name":"SS Innovations International, Inc.","filed_at":"2026-03-09T23:59:59+00:00","discovered_at":"2026-05-14T18:02:35.862487+00:00","generated_at":"2026-05-15T17:55:24.271893+00:00","sec_items":["3.02","9.01"],"event_type":"other_material","sentiment":"positive","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"SS Innovations completes $18.6M private placement; funds expansion, FDA review mid-2026","bullets":["Raised $18.6M gross via private placement of 5,774,839 shares at $3.00-$4.01 per share.","Insiders invested $5.2M: CEO ($2.0M), Vice Chairman Moll ($2.0M), Director Adams ($1.2M).","External investors, led by Manipal Global Health Services, invested $13.4M at $3.00/share.","Proceeds for working capital, global expansion, and preparation for US/EU market entry.","FDA 510(k) review for SSi Mantra system expected mid-2026; CE marking targeted in 2026."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-024938","json":"https://secwatch.observer/filing/0001213900-26-024938.json","markdown":"https://secwatch.observer/filing/0001213900-26-024938.md","text":"https://secwatch.observer/filing/0001213900-26-024938.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/0001213900-26-024938-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/ea0280514-8k_ssinno.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T17:55:24.271893+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"2c96408902624071884b9868d863da537951d28b","claim":"SS Innovations International, Inc. issued warrants to purchase 41,667 shares of our common stock of warrant to a FINRA member firm for exercise price of $3.45 per share.","evidence_excerpt":"the Company will pay a FINRA member firm a cash commission of $175,000 (7% of the investment) and issue to such firm five-year warrants to purchase 41,667 shares of our common stock at an exercise price of $3.45 per share","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/0001213900-26-024938-index.htm","confidence":0.97,"family_label":"Equity Issuances","details":[{"label":"Security","value":"warrant"},{"label":"Shares","value":"warrants to purchase 41,667 shares of our common stock"},{"label":"Purchaser","value":"a FINRA member firm"},{"label":"Consideration","value":"exercise price of $3.45 per share"}],"fact_type":"equity_issuance"},{"claim_id":"91f0b81087449f7572e4ed20d294edd4048d018f","claim":"SS Innovations International, Inc. issued 1,300,006 shares of common stock to Dr. Sudhir Srivastava, Dr. Frederic Moll, and Tim Adams for at an average price of $4.00 per share for a total of approximately $5.2 million.","evidence_excerpt":"an aggregate of 1,300,006 shares of common stock at an average price of $4.00 per share for a total of approximately $5.2 million, to Dr. Sudhir Srivastava, our Chairman and Chief Executive Officer (498,753 shares at $4.01 per share for a total of $2.0 million), Dr. Frederic Moll, our Vice Chairman (501,253 shares at $3.99 per share for a total of $2.0 million), and Tim Adams, a director (300,000 shares at $3.99 per share for a total of $1.2 million)","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/0001213900-26-024938-index.htm","confidence":0.98,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"1,300,006 shares"},{"label":"Purchaser","value":"Dr. Sudhir Srivastava, Dr. Frederic Moll, and Tim Adams"},{"label":"Consideration","value":"at an average price of $4.00 per share for a total of approximately $5.2 million"}],"fact_type":"equity_issuance"},{"claim_id":"ec4cb412e1995521544a14721cb2909f8639468f","claim":"SS Innovations International, Inc. issued 4,474,833 shares of common stock of common stock to existing and new investors, led by Manipal Global Health Services for at $3.00 per share for a total of approximately $13.4 million.","evidence_excerpt":"an aggregate of 4,474,833 shares of common stock at $3.00 per share for a total of approximately $13.4 million, to existing and new investors, led by Manipal Global Health Services","evidence_source":"SEC 8-K Item 3.02/3.03","evidence_url":"https://www.sec.gov/Archives/edgar/data/1676163/000121390026024938/0001213900-26-024938-index.htm","confidence":0.98,"family_label":"Equity Issuances","details":[{"label":"Security","value":"common stock"},{"label":"Shares","value":"4,474,833 shares of common stock"},{"label":"Purchaser","value":"existing and new investors, led by Manipal Global Health Services"},{"label":"Consideration","value":"at $3.00 per share for a total of approximately $13.4 million"}],"fact_type":"equity_issuance"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}